M. Llamas

Spanish Consensus Document on the Treatment Algorithm for Rosacea.

C. Nadal, M. Schaller, M. Salleras, 2019, Actas dermo-sifiliograficas.

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry.

F. Vanaclocha, I. García-Doval, P. Dávila-Seijo, 2017, The Journal of investigative dermatology.

Spanish Consensus Document on the Treatment Algorithm for Rosacea

C. Nadal, M. Schaller, M. Salleras, 2019, Actas Dermo-Sifiliográficas (English Edition).

Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis

F. Vanaclocha, I. García-Doval, P. Dávila-Seijo, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Unusual allergic contact dermatitis produced by a transcutaneous electrical nerve stimulator

A. García‐Díez, J. Sánchez‐Pérez, M. Llamas, 2010, Contact dermatitis.

Follicular mucinosis in a mycosis fungoides‐like hypersensitivity syndrome induced by oxcarbamazepine

A. García‐Díez, J. Sánchez‐Pérez, J. Fraga, 2011, Journal of cutaneous pathology.

Real‐world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group

D. Vidal, I. Belinchón, G. Carretero, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis Group

D. Vidal, J. Carrascosa, M. Ferran, 2022, Dermatologic therapy.

Awareness about possible reactivation of HBsAg‐negative patients when prescribing biological therapy

E. Dauden, M. Llamas, R. Navarro, 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts

F. Vanaclocha, I. García-Doval, R. Sanmartí, 2017, The British journal of dermatology.